Mr. Sushil K Mehandru, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1925 Hwy 35 W, Wall, NJ 07719 Phone: 732-974-0100 Fax: 732-974-0137 |
News Archive
Duke University Medical Center researchers at have found a strong correlation between caffeine intake at mealtime and increased glucose and insulin levels among people with type-2 diabetes.
Debiopharm Group, SA (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, today presented the 'Debiopharm Life Sciences Award' to Dr Lluis Quintana-Murci from the Institut Pasteur in France, for his outstanding innovative research in the emerging field of evolutionary genetics of infection.
A new study examining why young South Asian heart attack patients have more adverse outcomes found this patient population was often obese, used tobacco products, and had a family history of heart disease or risk factors that could have been prevented, monitored for or treated before heart attacks happen.
Amgen today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency via the centralized procedure for etelcalcetide (formerly AMG 416) for the treatment of secondary hyperparathyroidism (SHPT) in adult patients with chronic kidney disease (CKD) on hemodialysis therapy. If approved, etelcalcetide will be the first calcimimetic agent that can be administered intravenously.
As most new moms know, post-baby weight can be frustratingly hard to lose. That's why Jennifer, a 24 year old mom from Dallas-Fort Worth, Texas chose to get a little help with an ORBERA™ Intragastric Balloon procedure from True Results. Jennifer is the first patient in Texas to get this new FDA approved weight loss procedure.
› Verified 3 days ago